Our bioinformatics investigation of the TCGA database [112] provides additional information—it showed that RARA and RXRA receptor levels are prognostic (p < 0.05) of CRC patient survival (Figure 3) [17]. The gene discussed is RARA; the disease is colorectal carcinoma.